Four Key Scientists Behind the Vaccines to Share Virtual Stage at November 10 Event; Katalin Karikó, Ugur Sahin, Özlem Türeci, and Drew Weissman to Receive 2021 William B. Coley Award for Distinguished Research in Basic Immunology; Overdue Opportunity to Understand mRNA’s Origins and Future in Cancer Research
The first patients have enrolled in a platform clinical trial, called REVOLUTION, testing combination immunotherapy in patients with metastatic pancreatic cancer. The study uses an innovative design to test multiple combination therapies in parallel.
CRI's free and live online event for patients and caregivers covering cancer immunotherapy, clinical trials, and cancer care disparities takes place Oct. 7-8, 2021.
CRI’s free virtual event to connect U.S. Hispanic cancer patients and caregivers with leading cancer experts to discuss breakthroughs in immunotherapy, patient successes, and clinical trials, will be held on September 16, 2021, at 2 p.m. ET
New CRI health equity program supports young Black, Hispanic, and Latino scientists in the fields of immunology and immuno-oncology at top academic research institutions
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Meet three promising young scientists changing the face of immuno-oncology: Ryan K. Alexander, Ph.D., of Boston Children’s Hospital; Nelson M. LaMarche, Ph.D., of the Icahn School of Medicine at Mount Sinai; and Christopher B. Medina, Ph.D., of Emory University.
New research, new treatments, and how we’re working toward a future immune to cervical cancer